Log in to save to my catalogue

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_281489

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline

About this item

Full title

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline

Publisher

United States: Elsevier Inc

Journal title

Alzheimer's & dementia : translational research & clinical interventions, 2019, Vol.5 (1), p.129-138

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

More information

Scope and Contents

Contents

Neurodegeneration appears to be the biological mechanism most proximate to cognitive decline in Alzheimer's disease. We test whether t-tau and alternative biomarkers of neurodegeneration—neurogranin and neurofilament light protein (NFL)—add value in predicting subclinical cognitive decline.
One hundred fifty cognitively unimpaired participants r...

Alternative Titles

Full title

Differential effects of neurodegeneration biomarkers on subclinical cognitive decline

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_swepub_primary_oai_gup_ub_gu_se_281489

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_swepub_primary_oai_gup_ub_gu_se_281489

Other Identifiers

ISSN

2352-8737

E-ISSN

2352-8737

DOI

10.1016/j.trci.2019.02.004

How to access this item